<code id='957F96DF01'></code><style id='957F96DF01'></style>
    • <acronym id='957F96DF01'></acronym>
      <center id='957F96DF01'><center id='957F96DF01'><tfoot id='957F96DF01'></tfoot></center><abbr id='957F96DF01'><dir id='957F96DF01'><tfoot id='957F96DF01'></tfoot><noframes id='957F96DF01'>

    • <optgroup id='957F96DF01'><strike id='957F96DF01'><sup id='957F96DF01'></sup></strike><code id='957F96DF01'></code></optgroup>
        1. <b id='957F96DF01'><label id='957F96DF01'><select id='957F96DF01'><dt id='957F96DF01'><span id='957F96DF01'></span></dt></select></label></b><u id='957F96DF01'></u>
          <i id='957F96DF01'><strike id='957F96DF01'><tt id='957F96DF01'><pre id='957F96DF01'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:417
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Sen. Paul opposes bill to ban Chinese biotechs
          Sen. Paul opposes bill to ban Chinese biotechs

          Sen.RandPaul(R-Ky.)WinMcNamee/GettyImagesWASHINGTON—ASenatepanelWednesdaypassedabillaimedatpreventin

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          AstraZeneca bets AAV gene therapy will still deliver the goods

          AlastairGrant/APSengChenghasbeenworkingingenetherapyfornearlyaslongasgenetherapyhasbeenafield.Asayou